Jenny McIntosh

6.2k total citations
44 papers, 1.8k citations indexed

About

Jenny McIntosh is a scholar working on Genetics, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Jenny McIntosh has authored 44 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Genetics, 28 papers in Molecular Biology and 8 papers in Infectious Diseases. Recurrent topics in Jenny McIntosh's work include Virus-based gene therapy research (31 papers), CRISPR and Genetic Engineering (14 papers) and RNA Interference and Gene Delivery (7 papers). Jenny McIntosh is often cited by papers focused on Virus-based gene therapy research (31 papers), CRISPR and Genetic Engineering (14 papers) and RNA Interference and Gene Delivery (7 papers). Jenny McIntosh collaborates with scholars based in United Kingdom, United States and Germany. Jenny McIntosh's co-authors include Amit C. Nathwani, Andrew M. Davidoff, Edward G. D. Tuddenham, John T. Gray, Catherine Y. Ng, Simon N. Waddington, Yunyu Spence, Junfang Zhou, Melanie Cochrane and Geoffrey Kemball‐Cook and has published in prestigious journals such as Blood, Genetics and The FASEB Journal.

In The Last Decade

Jenny McIntosh

42 papers receiving 1.8k citations

Peers

Jenny McIntosh
Giridhara R. Jayandharan India
David M. Markusic United States
Leszek Lisowski Australia
Steven J. Howe United Kingdom
Markus Hildinger Germany
Gregory M. Podsakoff United States
Cynthia C. Bartholomae Germany
Denise E. Sabatino United States
Peter Colosi United States
Yasuji Ueda Japan
Giridhara R. Jayandharan India
Jenny McIntosh
Citations per year, relative to Jenny McIntosh Jenny McIntosh (= 1×) peers Giridhara R. Jayandharan

Countries citing papers authored by Jenny McIntosh

Since Specialization
Citations

This map shows the geographic impact of Jenny McIntosh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jenny McIntosh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jenny McIntosh more than expected).

Fields of papers citing papers by Jenny McIntosh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jenny McIntosh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jenny McIntosh. The network helps show where Jenny McIntosh may publish in the future.

Co-authorship network of co-authors of Jenny McIntosh

This figure shows the co-authorship network connecting the top 25 collaborators of Jenny McIntosh. A scholar is included among the top collaborators of Jenny McIntosh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jenny McIntosh. Jenny McIntosh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Muczynski, Vincent, Olivier D. Christophe, Alain P. Guérin, et al.. (2025). Alternative AAV gene therapy for hemophilia A using expression of Bi8, a novel single-chain FVIII-mimetic antibody. Blood. 146(26). 3175–3187.
2.
Delignat, Sandrine, Maxime Lecerf, Rémi Noé, et al.. (2023). Transplacental delivery of therapeutic proteins by engineered immunoglobulin G: a step toward perinatal replacement therapy. Journal of Thrombosis and Haemostasis. 21(9). 2405–2417. 5 indexed citations
3.
Li, Yisheng, Jenny McIntosh, Wenyi Wang, et al.. (2023). BV6, AN ANTAGONIST OF INHIBITOR OF APOPTOSIS PROTEINS, SENSITIZES RESISTANT MANTLE CELL LYMPHOMA CELLS TO VENETOCLAX. Hematological Oncology. 41(S2). 797–797. 1 indexed citations
4.
Nathwani, Amit C., Jenny McIntosh, & Rose Sheridan. (2022). Liver Gene Therapy. Human Gene Therapy. 33(17-18). 879–888. 18 indexed citations
5.
Nathwani, Amit C., Ulrike M. Reiss, Edward G. D. Tuddenham, et al.. (2018). Adeno-Associated Mediated Gene Transfer for Hemophilia B:8 Year Follow up and Impact of Removing "Empty Viral Particles" on Safety and Efficacy of Gene Transfer. Blood. 132(Supplement 1). 491–491. 94 indexed citations
6.
Nathwani, Amit C., Edward G. D. Tuddenham, Pratima Chowdary, et al.. (2018). GO-8: Preliminary Results of a Phase I/II Dose Escalation Trial of Gene Therapy for Haemophilia a Using a Novel Human Factor VIII Variant. Blood. 132(Supplement 1). 489–489. 43 indexed citations
7.
Pytel, Kamila M, Jean‐François Gélinas, Jenny McIntosh, et al.. (2018). The murine lung as a factory to produce secreted intrapulmonary and circulatory proteins. Gene Therapy. 25(5). 345–358. 11 indexed citations
8.
Chowdary, Pratima, Andrew M. Davidoff, Ulrike M. Reiss, et al.. (2018). A Single Intravenous Infusion of FLT180a Results in Factor IX Activity Levels of More Than 40% and Has the Potential to Provide a Functional Cure for Patients with Haemophilia B. Blood. 132(Supplement 1). 631–631. 19 indexed citations
9.
Chan, Jerry Kok Yen, Irene Gil-Fariña, Cecilia Rosales, et al.. (2018). Therapeutic expression of human clotting factors IX and × following adeno‐associated viral vector‐mediated intrauterine gene transfer in early‐gestation fetal macaques. The FASEB Journal. 33(3). 3954–3967. 25 indexed citations
10.
Foley, Jonathan H., Jenny McIntosh, Romuald Corbau, et al.. (2018). A Novel Lysine to Arginine Substitution at Position 301 Enhances Activity of Factor IX. Blood. 132(Supplement 1). 3772–3772. 1 indexed citations
11.
Quellec, Sandra Le, Allison Dane, Nathalie Enjolras, et al.. (2018). Potential limits of AAV‐based gene therapy with the use of new transgenes expressing factor IX fusion proteins. Haemophilia. 25(1). e11–e18. 3 indexed citations
12.
Mattar, Citra Nurfarah Zaini, Irene Gil-Fariña, Cecilia Rosales, et al.. (2017). In Utero Transfer of Adeno-Associated Viral Vectors Produces Long-Term Factor IX Levels in a Cynomolgus Macaque Model. Molecular Therapy. 25(8). 1843–1853. 37 indexed citations
13.
Mattar, Citra Nurfarah Zaini, Amit C. Nathwani, Simon N. Waddington, et al.. (2011). Stable Human FIX Expression After 0.9G Intrauterine Gene Transfer of Self-complementary Adeno-associated Viral Vector 5 and 8 in Macaques. Molecular Therapy. 19(11). 1950–1960. 44 indexed citations
14.
Ward, Natalie J, Suzanne M. K. Buckley, Simon N. Waddington, et al.. (2010). Codon optimization of human factor VIII cDNAs leads to high-level expression. Blood. 117(3). 798–807. 148 indexed citations
15.
Georgiadis, Anastasios, Marion Tschernutter, James Bainbridge, et al.. (2009). AAV-mediated knockdown of Peripherin-2 in vivo using miRNA-based hairpins. Gene Therapy. 17(4). 486–493. 41 indexed citations
16.
Tan, Mei Hong, Alexander J. Smith, Basil S. Pawlyk, et al.. (2009). Gene therapy for retinitis pigmentosa and Leber congenital amaurosis caused by defects in AIPL1: effective rescue of mouse models of partial and complete Aipl1 deficiency using AAV2/2 and AAV2/8 vectors. Human Molecular Genetics. 18(12). 2099–2114. 90 indexed citations
17.
Carlisle, Robert, Reuben Benjamin, Simon S. Briggs, et al.. (2008). Coating of adeno‐associated virus with reactive polymers can ablate virus tropism, enable retargeting and provide resistance to neutralising antisera. The Journal of Gene Medicine. 10(4). 400–411. 53 indexed citations
18.
Cochrane, Melanie, et al.. (2008). Enhancing transduction of the liver by adeno-associated viral vectors. Gene Therapy. 16(1). 60–69. 61 indexed citations
19.
20.
Natkunarajah, M, Jenny McIntosh, Yanaí Durán, et al.. (2007). Assessment of ocular transduction using single-stranded and self-complementary recombinant adeno-associated virus serotype 2/8. Gene Therapy. 15(6). 463–467. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giridhara R. Jayandharan Breakdown of academic impact, for papers by David M. Markusic Breakdown of academic impact, for papers by Leszek Lisowski Breakdown of academic impact, for papers by Steven J. Howe Breakdown of academic impact, for papers by Markus Hildinger Breakdown of academic impact, for papers by Gregory M. Podsakoff Breakdown of academic impact, for papers by Cynthia C. Bartholomae Breakdown of academic impact, for papers by Denise E. Sabatino Breakdown of academic impact, for papers by Peter Colosi Breakdown of academic impact, for papers by Yasuji Ueda
Rankless by CCL
2026